Gene Page: MSN
Summary ?
GeneID | 4478 |
Symbol | MSN |
Synonyms | HEL70 |
Description | moesin |
Reference | MIM:309845|HGNC:HGNC:7373|Ensembl:ENSG00000147065|HPRD:02399|Vega:OTTHUMG00000021723 |
Gene type | protein-coding |
Map location | Xq11.1 |
Sherlock p-value | 0.86 |
Support | CompositeSet Potential synaptic genes |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
PMID:cooccur | High-throughput literature-search | Systematic search in PubMed for genes co-occurring with SCZ keywords. A total of 3027 genes were included. | |
Literature | High-throughput literature-search | Co-occurance with Schizophrenia keywords: schizophrenia,schizophrenic,schizophrenics,schizotypy,schizophrenias,schizotypal | Click to show details |
GO_Annotation | Mapping neuro-related keywords to Gene Ontology annotations | Hits with neuro-related keywords: 3 | |
Network | Shortest path distance of core genes in the Human protein-protein interaction network | Contribution to shortest path in PPI network: 0.004 |
Section I. Genetics and epigenetics annotation
Section II. Transcriptome annotation
General gene expression (GTEx)

Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
ENHO | 0.92 | 0.89 |
SCRG1 | 0.91 | 0.93 |
MT1E | 0.90 | 0.97 |
MT1G | 0.89 | 0.89 |
S100A13 | 0.88 | 0.92 |
C2orf82 | 0.88 | 0.88 |
AC044839.2 | 0.87 | 0.91 |
PSMB8 | 0.87 | 0.90 |
TMEM219 | 0.86 | 0.79 |
CBR3 | 0.86 | 0.86 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
MCM3AP | -0.72 | -0.84 |
PDXDC1 | -0.72 | -0.84 |
USP7 | -0.71 | -0.80 |
CKAP5 | -0.71 | -0.85 |
HEATR5B | -0.71 | -0.85 |
GIGYF2 | -0.71 | -0.81 |
RBM26 | -0.71 | -0.85 |
ABCF1 | -0.71 | -0.76 |
RNASEN | -0.71 | -0.88 |
ANKRD17 | -0.71 | -0.81 |
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0005102 | receptor binding | IPI | Neurotransmitter (GO term level: 4) | 15819698 |
GO:0005200 | structural constituent of cytoskeleton | TAS | 1924289 | |
GO:0008092 | cytoskeletal protein binding | IEA | - | |
GO:0050839 | cell adhesion molecule binding | IPI | 12082081 | |
Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0022614 | membrane to membrane docking | IEP | 12082081 | |
GO:0006928 | cell motion | TAS | 16130169 | |
GO:0007159 | leukocyte adhesion | IEP | 12082081 | |
GO:0050900 | leukocyte migration | IEP | 12082081 | |
Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0030175 | filopodium | IDA | axon (GO term level: 5) | 12082081 |
GO:0001931 | uropod | IEA | Synap (GO term level: 5) | - |
GO:0005856 | cytoskeleton | TAS | 16130169 | |
GO:0005737 | cytoplasm | IEA | - | |
GO:0005902 | microvillus | IDA | 12082081 | |
GO:0005886 | plasma membrane | TAS | 1924289 |8188263 | |
GO:0016323 | basolateral plasma membrane | IEA | - | |
GO:0016324 | apical plasma membrane | IEA | - | |
GO:0019898 | extrinsic to membrane | IEA | - |
Section IV. Protein-protein interaction annotation
Interactors | Aliases B | Official full name B | Experimental | Source | PubMed ID |
---|---|---|---|---|---|
ARHGDIA | GDIA1 | MGC117248 | RHOGDI | RHOGDI-1 | Rho GDP dissociation inhibitor (GDI) alpha | Co-purification | BioGRID | 15659383 |
BID | FP497 | MGC15319 | MGC42355 | BH3 interacting domain death agonist | Co-purification | BioGRID | 15659383 |
CASP10 | ALPS2 | FLICE2 | MCH4 | caspase 10, apoptosis-related cysteine peptidase | Co-purification | BioGRID | 15659383 |
CASP8 | ALPS2B | CAP4 | FLICE | FLJ17672 | MACH | MCH5 | MGC78473 | caspase 8, apoptosis-related cysteine peptidase | Co-purification | BioGRID | 15659383 |
CD46 | MCP | MGC26544 | MIC10 | TLX | TRA2.10 | CD46 molecule, complement regulatory protein | - | HPRD | 7884872|12082081 |
CD46 | MCP | MGC26544 | MIC10 | TLX | TRA2.10 | CD46 molecule, complement regulatory protein | - | HPRD,BioGRID | 7884872 |
CD93 | C1QR1 | C1qR(P) | C1qRP | CDw93 | MXRA4 | dJ737E23.1 | CD93 molecule | Moesin interacts with CD93. | BIND | 15819698 |
EZR | CVIL | CVL | DKFZp762H157 | FLJ26216 | MGC1584 | VIL2 | ezrin | - | HPRD,BioGRID | 7579708 |8248180 |
FADD | GIG3 | MGC8528 | MORT1 | Fas (TNFRSF6)-associated via death domain | Co-purification | BioGRID | 15659383 |
FAS | ALPS1A | APO-1 | APT1 | CD95 | FAS1 | FASTM | TNFRSF6 | Fas (TNF receptor superfamily, member 6) | Co-purification | BioGRID | 15659383 |
FASLG | APT1LG1 | CD178 | CD95L | FASL | TNFSF6 | Fas ligand (TNF superfamily, member 6) | Co-purification | BioGRID | 15659383 |
HLA-B | AS | HLA-B-7301 | HLA-B73 | HLAB | HLAC | SPDA1 | major histocompatibility complex, class I, B | Affinity Capture-MS | BioGRID | 17353931 |
ICAM1 | BB2 | CD54 | P3.58 | intercellular adhesion molecule 1 | - | HPRD | 12082081 |
ICAM2 | CD102 | intercellular adhesion molecule 2 | - | HPRD,BioGRID | 9472040 |
ICAM3 | CD50 | CDW50 | ICAM-R | intercellular adhesion molecule 3 | - | HPRD,BioGRID | 11784723 |
L1CAM | CAML1 | CD171 | HSAS | HSAS1 | MASA | MIC5 | N-CAML1 | S10 | SPG1 | L1 cell adhesion molecule | - | HPRD | 12070130 |
MAPK8 | JNK | JNK1 | JNK1A2 | JNK21B1/2 | PRKM8 | SAPK1 | mitogen-activated protein kinase 8 | Co-purification | BioGRID | 15659383 |
MSN | - | moesin | - | HPRD,BioGRID | 10847681 |
NCF1 | FLJ79451 | NCF1A | NOXO2 | SH3PXD1A | p47phox | neutrophil cytosolic factor 1 | Affinity Capture-Western Reconstituted Complex | BioGRID | 11716484 |
NCF4 | MGC3810 | NCF | P40PHOX | SH3PXD4 | neutrophil cytosolic factor 4, 40kDa | - | HPRD,BioGRID | 11716484 |
PLEC1 | EBS1 | EBSO | HD1 | PCN | PLEC1b | PLTN | plectin 1, intermediate filament binding protein 500kDa | - | HPRD,BioGRID | 11441066 |
RHOA | ARH12 | ARHA | RHO12 | RHOH12 | ras homolog gene family, member A | Co-purification | BioGRID | 15659383 |
SELL | CD62L | LAM-1 | LAM1 | LECAM1 | LNHR | LSEL | LYAM1 | Leu-8 | Lyam-1 | PLNHR | TQ1 | hLHRc | selectin L | Reconstituted Complex | BioGRID | 11706008 |
SELPLG | CD162 | CLA | PSGL-1 | PSGL1 | selectin P ligand | - | HPRD,BioGRID | 12115638 |
SLC9A3R1 | EBP50 | NHERF | NHERF1 | NPHLOP2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | moesin interacts with hNHE-RF. | BIND | 9430655 |
SLC9A3R1 | EBP50 | NHERF | NHERF1 | NPHLOP2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | - | HPRD,BioGRID | 9430655 |
SPN | CD43 | GPL115 | LSN | sialophorin | - | HPRD,BioGRID | 9616160 |
SYK | DKFZp313N1010 | FLJ25043 | FLJ37489 | spleen tyrosine kinase | Syk interacts with moesin. This interaction was modeled on a demonstrated interaction between Syk and moesin from unspecified species. | BIND | 12387735 |
TNFRSF10B | CD262 | DR5 | KILLER | KILLER/DR5 | TRAIL-R2 | TRAILR2 | TRICK2 | TRICK2A | TRICK2B | TRICKB | ZTNFR9 | tumor necrosis factor receptor superfamily, member 10b | Co-purification | BioGRID | 15659383 |
TNFRSF1A | CD120a | FPF | MGC19588 | TBP1 | TNF-R | TNF-R-I | TNF-R55 | TNFAR | TNFR1 | TNFR55 | TNFR60 | p55 | p55-R | p60 | tumor necrosis factor receptor superfamily, member 1A | Co-purification | BioGRID | 15659383 |
TSC1 | KIAA0243 | LAM | MGC86987 | TSC | tuberous sclerosis 1 | - | HPRD,BioGRID | 12226091 |
TSC1 | KIAA0243 | LAM | MGC86987 | TSC | tuberous sclerosis 1 | Hamartin interacts with moesin. This interaction was modeled on a demonstrated interaction between murine hamartin and human moesin. | BIND | 10806479 |
VCAM1 | CD106 | DKFZp779G2333 | INCAM-100 | MGC99561 | vascular cell adhesion molecule 1 | - | HPRD,BioGRID | 12082081 |
VCAM1 | CD106 | DKFZp779G2333 | INCAM-100 | MGC99561 | vascular cell adhesion molecule 1 | - | HPRD | 7884872|12082081 |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
KEGG LEUKOCYTE TRANSENDOTHELIAL MIGRATION | 118 | 78 | All SZGR 2.0 genes in this pathway |
KEGG REGULATION OF ACTIN CYTOSKELETON | 216 | 144 | All SZGR 2.0 genes in this pathway |
PID RHOA PATHWAY | 45 | 33 | All SZGR 2.0 genes in this pathway |
PID ER NONGENOMIC PATHWAY | 41 | 35 | All SZGR 2.0 genes in this pathway |
REACTOME DEVELOPMENTAL BIOLOGY | 396 | 292 | All SZGR 2.0 genes in this pathway |
REACTOME AXON GUIDANCE | 251 | 188 | All SZGR 2.0 genes in this pathway |
REACTOME L1CAM INTERACTIONS | 86 | 62 | All SZGR 2.0 genes in this pathway |
REACTOME RECYCLING PATHWAY OF L1 | 27 | 15 | All SZGR 2.0 genes in this pathway |
ONKEN UVEAL MELANOMA UP | 783 | 507 | All SZGR 2.0 genes in this pathway |
SCHUETZ BREAST CANCER DUCTAL INVASIVE UP | 351 | 230 | All SZGR 2.0 genes in this pathway |
DAVICIONI TARGETS OF PAX FOXO1 FUSIONS UP | 255 | 177 | All SZGR 2.0 genes in this pathway |
DIAZ CHRONIC MEYLOGENOUS LEUKEMIA UP | 1382 | 904 | All SZGR 2.0 genes in this pathway |
CHARAFE BREAST CANCER LUMINAL VS BASAL DN | 455 | 304 | All SZGR 2.0 genes in this pathway |
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL DN | 460 | 312 | All SZGR 2.0 genes in this pathway |
GRAESSMANN APOPTOSIS BY DOXORUBICIN DN | 1781 | 1082 | All SZGR 2.0 genes in this pathway |
GRAESSMANN RESPONSE TO MC AND DOXORUBICIN DN | 770 | 415 | All SZGR 2.0 genes in this pathway |
BERENJENO TRANSFORMED BY RHOA UP | 536 | 340 | All SZGR 2.0 genes in this pathway |
LANG MYB FAMILY TARGETS | 29 | 16 | All SZGR 2.0 genes in this pathway |
LINDGREN BLADDER CANCER CLUSTER 2B | 392 | 251 | All SZGR 2.0 genes in this pathway |
LINDGREN BLADDER CANCER HIGH RECURRENCE | 49 | 31 | All SZGR 2.0 genes in this pathway |
FARMER BREAST CANCER BASAL VS LULMINAL | 330 | 215 | All SZGR 2.0 genes in this pathway |
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP | 83 | 51 | All SZGR 2.0 genes in this pathway |
GRUETZMANN PANCREATIC CANCER UP | 358 | 245 | All SZGR 2.0 genes in this pathway |
KOYAMA SEMA3B TARGETS UP | 292 | 168 | All SZGR 2.0 genes in this pathway |
WU CELL MIGRATION | 184 | 114 | All SZGR 2.0 genes in this pathway |
BENPORATH MYC TARGETS WITH EBOX | 230 | 156 | All SZGR 2.0 genes in this pathway |
GEORGES TARGETS OF MIR192 AND MIR215 | 893 | 528 | All SZGR 2.0 genes in this pathway |
TARTE PLASMA CELL VS PLASMABLAST DN | 309 | 206 | All SZGR 2.0 genes in this pathway |
FERNANDEZ BOUND BY MYC | 182 | 116 | All SZGR 2.0 genes in this pathway |
FLECHNER BIOPSY KIDNEY TRANSPLANT OK VS DONOR UP | 555 | 346 | All SZGR 2.0 genes in this pathway |
LEI MYB TARGETS | 318 | 215 | All SZGR 2.0 genes in this pathway |
TAKAO RESPONSE TO UVB RADIATION UP | 86 | 55 | All SZGR 2.0 genes in this pathway |
REN ALVEOLAR RHABDOMYOSARCOMA DN | 408 | 274 | All SZGR 2.0 genes in this pathway |
LU AGING BRAIN UP | 262 | 186 | All SZGR 2.0 genes in this pathway |
BURTON ADIPOGENESIS 8 | 86 | 57 | All SZGR 2.0 genes in this pathway |
HEDENFALK BREAST CANCER BRCA1 VS BRCA2 | 163 | 113 | All SZGR 2.0 genes in this pathway |
ZHONG SECRETOME OF LUNG CANCER AND FIBROBLAST | 132 | 93 | All SZGR 2.0 genes in this pathway |
MARSON BOUND BY E2F4 UNSTIMULATED | 728 | 415 | All SZGR 2.0 genes in this pathway |
RIGGINS TAMOXIFEN RESISTANCE UP | 66 | 44 | All SZGR 2.0 genes in this pathway |
SMID BREAST CANCER LUMINAL B DN | 564 | 326 | All SZGR 2.0 genes in this pathway |
SMID BREAST CANCER BASAL UP | 648 | 398 | All SZGR 2.0 genes in this pathway |
HUANG DASATINIB RESISTANCE UP | 81 | 53 | All SZGR 2.0 genes in this pathway |
NUTT GBM VS AO GLIOMA UP | 46 | 34 | All SZGR 2.0 genes in this pathway |
CHANG CORE SERUM RESPONSE UP | 212 | 128 | All SZGR 2.0 genes in this pathway |
VANTVEER BREAST CANCER ESR1 DN | 240 | 153 | All SZGR 2.0 genes in this pathway |
HSIAO HOUSEKEEPING GENES | 389 | 245 | All SZGR 2.0 genes in this pathway |
HOSHIDA LIVER CANCER SUBCLASS S1 | 237 | 159 | All SZGR 2.0 genes in this pathway |
DANG REGULATED BY MYC DN | 253 | 192 | All SZGR 2.0 genes in this pathway |
DANG MYC TARGETS DN | 31 | 25 | All SZGR 2.0 genes in this pathway |
DANG BOUND BY MYC | 1103 | 714 | All SZGR 2.0 genes in this pathway |
WONG ADULT TISSUE STEM MODULE | 721 | 492 | All SZGR 2.0 genes in this pathway |
KARLSSON TGFB1 TARGETS UP | 127 | 78 | All SZGR 2.0 genes in this pathway |
WANG RESPONSE TO GSK3 INHIBITOR SB216763 DN | 374 | 217 | All SZGR 2.0 genes in this pathway |
DEMAGALHAES AGING UP | 55 | 39 | All SZGR 2.0 genes in this pathway |
PILON KLF1 TARGETS DN | 1972 | 1213 | All SZGR 2.0 genes in this pathway |
PASINI SUZ12 TARGETS DN | 315 | 215 | All SZGR 2.0 genes in this pathway |
SERVITJA ISLET HNF1A TARGETS UP | 163 | 111 | All SZGR 2.0 genes in this pathway |
Section VI. microRNA annotation
miRNA family | Target position | miRNA ID | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
miR-122 | 48 | 54 | m8 | hsa-miR-122a | UGGAGUGUGACAAUGGUGUUUGU |
miR-133 | 140 | 147 | 1A,m8 | hsa-miR-133a | UUGGUCCCCUUCAACCAGCUGU |
hsa-miR-133b | UUGGUCCCCUUCAACCAGCUA | ||||
miR-192/215 | 1601 | 1607 | m8 | hsa-miR-192 | CUGACCUAUGAAUUGACAGCC |
hsa-miR-215 | AUGACCUAUGAAUUGACAGAC | ||||
miR-200bc/429 | 1574 | 1581 | 1A,m8 | hsa-miR-200b | UAAUACUGCCUGGUAAUGAUGAC |
hsa-miR-200c | UAAUACUGCCGGGUAAUGAUGG | ||||
hsa-miR-429 | UAAUACUGUCUGGUAAAACCGU | ||||
miR-217 | 1703 | 1709 | m8 | hsa-miR-217 | UACUGCAUCAGGAACUGAUUGGAU |
miR-27 | 1794 | 1800 | 1A | hsa-miR-27abrain | UUCACAGUGGCUAAGUUCCGC |
hsa-miR-27bbrain | UUCACAGUGGCUAAGUUCUGC | ||||
miR-491 | 43 | 50 | 1A,m8 | hsa-miR-491brain | AGUGGGGAACCCUUCCAUGAGGA |
miR-96 | 2012 | 2018 | m8 | hsa-miR-96brain | UUUGGCACUAGCACAUUUUUGC |
hsa-miR-96brain | UUUGGCACUAGCACAUUUUUGC |
- SZ: miRNAs which differentially expressed in brain cortex of schizophrenia patients comparing with control samples using microarray. Click here to see the list of SZ related miRNAs.
- Brain: miRNAs which are expressed in brain based on miRNA microarray expression studies. Click here to see the list of brain related miRNAs.